Genetically Engineered HSV-1 Phase 1 Study for the Treatment of Recurrent Malignant Glioma (M032-HSV-1)

Clinical Trial ID NCT02062827

PubWeight™ 9.72^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02062827

Top papers